Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort

被引：28

作者：

Williams-Gray, CH

Goris, A

Foltynie, T

Brown, J

Maranian, M

Walton, A

Compston, DAS

Sawcer, SJ

Barker, RA

机构：

[1] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge CB2 2PY, England

[2] Katholieke Univ Leuven, Lab Clin & Expt Neurol, Louvain, Belgium

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2006年 / 77卷 / 05期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1136/jnnp.2005.085019

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The LRRK2 G2019S mutation is the commonest genetic cause of Parkinson's disease (PD) identified to date, although estimates of its prevalence in idiopathic disease vary considerably. Our objectives were to determine G2019S mutation frequency in an unselected, community based cohort of idiopathic PD cases from the UK and to describe phenotypic characteristics among carriers. The mutation was present in two of 519 cases (0.4%) and none of 887 control individuals. The true prevalence of the mutation in idiopathic disease, its penetrance, and the phenotypic heterogeneity of associated cases have important implications for genetic screening in the clinical field.

引用

页码：665 / 667

页数：3

共 50 条

[41] Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson’s disease
Nicola du Toit
Riaan van Coller
David G. Anderson
Jonathan Carr
Soraya Bardien
[J]. neurogenetics, 2019, 20 : 215 - 218
[42] Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
Guedes, L. Correia
Ferreira, J. J.
Rosa, M. M.
Coelho, M.
Bonifati, V.
Sampaio, C.
[J]. PARKINSONISM & RELATED DISORDERS, 2010, 16 (04) : 237 - 242
[43] Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease
Kay, Denise M.
Bird, Tom D.
Zabetian, Cyrus P.
Factor, Stewart A.
Samii, Ali
Higgins, Donald S.
Nutt, John
Roberts, John W.
Griffith, Alida
Leis, Berta C.
Montimurro, Jennifer S.
Philpott, Sean
Payami, Haydeh
[J]. GENETIC TESTING, 2006, 10 (03): : 221 - 227
[44] Leukocyte MAPK activity associated with the LRRK2 G2019S mutation and Parkinson's disease
Aasly, J. O.
Toft, M.
Farrer, M. J.
Kvam, S. N.
White, L. R.
[J]. MOVEMENT DISORDERS, 2006, 21 : S416 - S416
[45] The G2019S LRRK2 mutation is frequent in north African families with Parkinson's disease
Lesage, S.
Ibanez, P.
Lohmann, E.
Pollak, P.
Tison, F.
Tazir, M.
Leutenegger, A. L.
Guimaraes, J.
Bonnet, A. M.
Durr, A.
Brice, A.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 31 - 32
[46] Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease
Marongiu, Roberta
Ghezzi, Daniele
Ialongo, Tamara
Soleti, Francesco
Elia, Antonio
Cavone, Stefania
Albanese, Alberto
Altavista, Maria Concetta
Barone, Paolo
Brusa, Livia
Cortelli, Pietro
Petrozzi, Lucia
Scaglione, Cesa
Stanzione, Paolo
Tinazzi, Michele
Zeviani, Massimo
Dallapiccola, Bruno
Bentivoglio, Anna Rita
Valente, Enza Maria
Garavaglia, Barbara
[J]. MOVEMENT DISORDERS, 2006, 21 (08) : 1232 - 1235
[47] LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India
Vijayan, Bejoy
Gopala, Srinivas
Kishore, Asha
[J]. NEUROLOGY INDIA, 2011, 59 (02) : 157 - 160
[48] The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease -: Is there a gender effect?
Orr-Urtreger, A.
Shifrin, C.
Rozovski, U.
Rosner, S.
Bercovich, D.
Gurevich, T.
Yagev-More, H.
Bar-Shira, A.
Giladi, N.
[J]. NEUROLOGY, 2007, 69 (16) : 1595 - 1602
[49] HIGH PREVALENCE AND REDUCED PENETRANCE OF LRRK2 G2019S MUTATION IN PARKINSON'S DISEASE PATIENTS FROM CANTABRIA
Infante, J.
Sierra, M.
Gonzalez-Aramburu, I.
Sanchez-Juan, P.
Berciano, J.
Combarros, O.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 238 - 238
[50] The natural history of Parkinson's disease in LRRK2 G2019S carriers
Kmiecik, M.
Coker, D.
Heilbron, K.
Aslibekyan, S.
Shelton, J.
Cannon, P.
Norcliffe-Kaufmann, L.
[J]. MOVEMENT DISORDERS, 2023, 38 : S497 - S497

← 1 2 3 4 5 →